Search Results - "Prostatic Neoplasms metabolism"
-
1
Authors: et al.
Contributors: et al.
Source: Mol Cancer
Molecular Cancer, Vol 24, Iss 1, Pp 1-26 (2025)Subject Terms: Male, Cancer therapy, Cell- och molekylärbiologi, Expression, Cell Movement/drug effects, Cell Proliferation/drug effects, Mice, 106023 Molekularbiologie, Platform, Cell Movement, Extracellular acidification, RC254-282, Set Enrichment Analysis, Tumor, Metabolic Reprogramming, 302055 Onkologie, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Men, 106023 Molecular biology, Prostatic Neoplasms/metabolism, Mitochondria, Type 2 diabetes mellitus (T2DM), Health, SDG 3 – Gesundheit und Wohlergehen, Metabolic rewiring, Pioglitazone/pharmacology, Efficacy, Oxygen consumption rate, Outcomes, Cell Line, Hypoglycemic Agents/pharmacology, SDG 3 - Good Health and Well-being, Cell Line, Tumor, Mitochondria/metabolism, Humans, Animals, Hypoglycemic Agents, 302055 Oncology, Mass-Spectrometry, PPAR gamma/agonists, Cell Proliferation, PPAR agonists, Pioglitazone, Research, Prostatic Neoplasms, Energy metabolism, Xenograft Model Antitumor Assays, PPAR gamma, Cell and Molecular Biology
File Description: application/pdf; application/zip; text/xml
-
2
Authors: et al.
Source: Eur J Nucl Med Mol Imaging
European journal of nuclear medicine and molecular imaging, vol. 51, no. 12, pp. 3753-3764Subject Terms: Male, Glutamate Carboxypeptidase II, Humans, Glutamate Carboxypeptidase II/metabolism, Antigens, Surface/metabolism, Prostatic Neoplasms/diagnostic imaging, Prostatic Neoplasms/metabolism, Bone and Bones/diagnostic imaging, Bone and Bones/metabolism, Positron-Emission Tomography/methods, Biological Transport, Radioactive Tracers, Radiopharmaceuticals/pharmacokinetics, Bone metastastes, PET, Positron Emission Tomography, Prostate cancer, Prostate specific membrane Antigen, UBU, Prostatic Neoplasms, Review Article, Bone and Bones, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Positron-Emission Tomography, Antigens, Surface, Radiopharmaceuticals
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/38884773
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_F504C36535AF4
https://serval.unil.ch/resource/serval:BIB_F504C36535AF.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_F504C36535AF
https://hdl.handle.net/11570/3319216
https://doi.org/10.1007/s00259-024-06797-5 -
3
Authors: et al.
Source: Oncogene
Subject Terms: Male, 0301 basic medicine, 0303 health sciences, Glutamine, Prostatic Neoplasms, Antineoplastic Agents, Docetaxel, Article, Oxidative Phosphorylation, 03 medical and health sciences, Glutaminase, Drug Resistance, Neoplasm, Cell Line, Tumor, 96/34, Cell Line, Tumor [MeSH], Prostatic Neoplasms/metabolism [MeSH], Prostatic Neoplasms/drug therapy [MeSH], Prostatic Neoplasms/pathology [MeSH], Antineoplastic Agents/pharmacology [MeSH], 96/109, 96/31, 13/51, Glutaminase/antagonists, Male [MeSH], 631/67/2327, Glutaminase/genetics [MeSH], 96/63, Drug Resistance, Neoplasm [MeSH], Docetaxel/pharmacology [MeSH], Humans [MeSH], Glutamine/metabolism [MeSH], 631/67/589/466, Oxidative Phosphorylation/drug effects [MeSH], Prostatic Neoplasms/genetics [MeSH], Glutaminase/metabolism [MeSH], Antineoplastic Agents/therapeutic use [MeSH], 38/89, 13/105, Cell Proliferation/drug effects [MeSH], article, Humans, Cell Proliferation
-
4
Authors: et al.
Source: Eur J Nucl Med Mol Imaging
Subject Terms: Male, Niacinamide, Aged, 80 and over, Fluorine Radioisotopes, Prostatic Neoplasms, Middle Aged, Radiation Dosage, 03 medical and health sciences, 0302 clinical medicine, Positron Emission Tomography Computed Tomography, Humans, Original Article, Whole Body Imaging, Radiopharmaceuticals, Oligopeptides, Aged, 80 and over [MeSH], Niacinamide/pharmacokinetics [MeSH], Aged [MeSH], Radiopharmaceuticals/pharmacokinetics [MeSH], Fluorine Radioisotopes/pharmacokinetics [MeSH], Kinetic modeling, Humans [MeSH], Dynamic PET, Positron Emission Tomography Computed Tomography [MeSH], Prostatic Neoplasms/metabolism [MeSH], Middle Aged [MeSH], Whole-body PET/CT, Prostatic Neoplasms/diagnostic imaging [MeSH], LAFOV PET/CT, Male [MeSH], Oligopeptides/pharmacokinetics [MeSH], Niacinamide/analogs, Whole Body Imaging [MeSH], [, Radiation Dosage [MeSH], Prostate cancer, Aged
-
5
Authors: et al.
Source: Molecular Imaging and Biology. 26:253-263
Subject Terms: Male, Prostate cancer, Tumor, Nude, Molecular imaging, Mice, Nude, Contrast Media, Prostatic Neoplasms, Second-wave phenomenon, Prostatic Neoplasms/metabolism, SDG 3 – Goede gezondheid en welzijn, Cell Line, 3. Good health, Mice, 03 medical and health sciences, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Nanobubbles, Cell Line, Tumor, Humans, Animals, Contrast-enhanced ultrasound, Ultrasonography
Access URL: https://pubmed.ncbi.nlm.nih.gov/38151581
-
6
Authors: et al.
Source: Mol Imaging Biol
Mamlins, Eduards; Scharbert, Lara; Cardinale, Jens; Krotov, Maria; Winter, Erik; Rathke, Hendrik; Strodel, Birgit; Ankrah, Alfred O; Sathekge, Mike; Haberkorn, Uwe; Kratochwil, Clemens; Giesel, Frederik L (2024). The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [99mTc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in Prostate Cancer. Molecular imaging and biology, 26(1), pp. 81-89. Springer-Verlag 10.1007/s11307-023-01881-y <http://dx.doi.org/10.1007/s11307-023-01881-y>
Molecular imaging & biology 26(1), 81-89 (2024). doi:10.1007/s11307-023-01881-ySubject Terms: Male, SDG-03: Good health and well-being, Prostate cancer, PSMA-GCK01, Technetium-99 m, Prostatic Neoplasms, 610 Medicine & health, Prostate-specific membrane antigen (PSMA), Theranostics, Ligands, 3. Good health, Molecular Docking Simulation, 03 medical and health sciences, Single-photon emission computed tomography (SPECT), 0302 clinical medicine, Humans, Tissue Distribution, Precision Medicine, Radiopharmaceuticals, Molecular Docking Simulation [MeSH], Edetic Acid/analogs, Humans [MeSH], Prostatic Neoplasms/metabolism [MeSH], Radiopharmaceuticals [MeSH], Retrospective Studies [MeSH], Prostatic Neoplasms/diagnostic imaging [MeSH], Ligands [MeSH], Male [MeSH], Tissue Distribution [MeSH], SPECT, Prostatic Neoplasms/therapy [MeSH], Precision Medicine [MeSH], Theranostic, Research Article, Edetic Acid, Retrospective Studies
File Description: application/pdf
-
7
Authors: et al.
Source: Oncogene
Subject Terms: Male, Receptors, Glucocorticoid, Cancer-Associated Fibroblasts, 38/77, 631/80/86/820, 13/21, Cell Line, Tumor [MeSH], Prostatic Neoplasms/metabolism [MeSH], Prostatic Neoplasms/drug therapy [MeSH], Receptors, Glucocorticoid/metabolism [MeSH], Male [MeSH], Prostate/pathology [MeSH], 45/91, 82/51, 631/80/79/750, Fibroblasts/metabolism [MeSH], 13/2, 38/32, Glucocorticoids/metabolism [MeSH], 631/80/86/2363, Humans [MeSH], Receptors, Glucocorticoid/genetics [MeSH], 631/67/589/466, Glucocorticoids/therapeutic use [MeSH], Prostatic Neoplasms/genetics [MeSH], Cancer-Associated Fibroblasts/metabolism [MeSH], Article, Glucocorticoids/pharmacology [MeSH], 96/106, article, Tumor Microenvironment [MeSH], Cell Line, Tumor, Prostate, Tumor Microenvironment, Humans, Prostatic Neoplasms, Fibroblasts, Glucocorticoids, 3. Good health
-
8
Authors: et al.
Source: Eur J Nucl Med Mol Imaging
Subject Terms: Cell Line, Tumor [MeSH], Glutamate Carboxypeptidase II/metabolism [MeSH], Swine [MeSH], Macaca fascicularis/metabolism [MeSH], Chelating Agents/chemistry [MeSH], Humans [MeSH], Thorium [MeSH], Small molecule conjugates, Prostate specific membrane antigen, Prostatic Neoplasms/metabolism [MeSH], Radiopharmaceuticals [MeSH], Antigens, Surface/metabolism [MeSH], Prostatic Neoplasms/diagnostic imaging [MeSH], Animals [MeSH], Original Article, Mice [MeSH], Male [MeSH], Thorium-227, Tissue Distribution [MeSH], Swine, Miniature/metabolism [MeSH], Prostate cancer, Targeted alpha therapy, Male, Glutamate Carboxypeptidase II, Swine, Thorium, Prostatic Neoplasms, 3. Good health, Mice, Macaca fascicularis, Cell Line, Tumor, Antigens, Surface, Humans, Animals, Swine, Miniature, Tissue Distribution, Radiopharmaceuticals, Chelating Agents
-
9
Authors: et al.
Source: J Exp Clin Cancer Res
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-21 (2024)Subject Terms: Male, 0301 basic medicine, 0303 health sciences, Prostate cancer, Research, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prostatic Neoplasms, Cellular senescence, Xenograft Model Antitumor Assays, Supraphysiological androgen level, Gene Expression Regulation, Neoplastic [MeSH], Cell Line, Tumor [MeSH], Cell Proliferation [MeSH], Long non-coding RNAs, Androgens/pharmacology [MeSH], Humans [MeSH], Prostatic Neoplasms/metabolism [MeSH], Prostatic Neoplasms/drug therapy [MeSH], Prostatic Neoplasms/pathology [MeSH], RNA, Long Noncoding/genetics [MeSH], Androgens/metabolism [MeSH], Animals [MeSH], Bipolar androgen therapy, Prostatic Neoplasms/genetics [MeSH], Mice [MeSH], Male [MeSH], Xenograft Model Antitumor Assays [MeSH], Cellular Senescence/drug effects [MeSH], Androgen receptor, Gene Expression Regulation, Neoplastic, Mice, 03 medical and health sciences, Cell Line, Tumor, Androgens, Humans, Animals, RNA, Long Noncoding, RC254-282, Cellular Senescence, Cell Proliferation
-
10
Authors: et al.
Source: Mol Cancer
Molecular Cancer, Vol 23, Iss 1, Pp 1-22 (2024)
Molecular CancerSubject Terms: Male, STAT3 Transcription Factor, Cytotoxic T-Cells, IL6ST/STAT3 Signaling, Senescence, Gene Expression Regulation, Neoplastic [MeSH], Immune cell infiltration, Cell Line, Tumor [MeSH], STAT3 Transcription Factor/metabolism [MeSH], Cytotoxic T-cells, Prostatic Neoplasms/metabolism [MeSH], IL6ST/STAT3 signaling, Prostatic Neoplasms/pathology [MeSH], Tumor Suppressor Protein p53/metabolism [MeSH], Tumor microenvironment, Senescence-associated secretory phenotype, Male [MeSH], Disease Models, Animal [MeSH], Prostate cancer, Cyclin-Dependent Kinase Inhibitor p16/metabolism [MeSH], Cellular Senescence [MeSH], Humans [MeSH], Animals [MeSH], Tumor Suppressor Protein p53/genetics [MeSH], Cyclin-Dependent Kinase Inhibitor p16/genetics [MeSH], Prostatic Neoplasms/genetics [MeSH], Mice [MeSH], L-gp130, Research, Signal Transduction [MeSH], Tumor Microenvironment [MeSH], Mice, SDG 3 - Good Health and Well-being, Cell Line, Tumor, Tumor Microenvironment, Animals, Humans, 302055 Oncology, RC254-282, Cellular Senescence, Cyclin-Dependent Kinase Inhibitor p16, Cancer och onkologi, Immune Cell Infiltration, Prostate Cancer, 302055 Onkologie, 106018 Human biology, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prostatic Neoplasms, 106018 Humanbiologie, Gene Expression Regulation, Neoplastic, Disease Models, Animal, Cancer and Oncology, SDG 3 – Gesundheit und Wohlergehen, Senescence-associated Secretory Phenotype, Tumor Suppressor Protein p53, Signal Transduction
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/39482716
https://doaj.org/article/b138c0eace4d4d388c5bcd9f679c1598
https://repository.publisso.de/resource/frl:6522547
https://phaidra.vetmeduni.ac.at/o:3743
https://doi.org/10.1186/s12943-024-02114-8
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-231912
http://urn.kb.se/resolve?urn=urn:nbn:se:mau:diva-72113 -
11
Authors: et al.
Source: Eur J Nucl Med Mol Imaging
Subject Terms: Male, Prostatectomy, Prostate, Prostatic Neoplasms, Gallium Radioisotopes, Prostate-Specific Antigen, 3. Good health, Surgery, Computer-Assisted, Positron Emission Tomography Computed Tomography, Humans, Original Article, Humans [MeSH], Prostatic Neoplasms/metabolism [MeSH], Retrospective Studies [MeSH], Neoplasm Recurrence, Local/pathology [MeSH], Prostatic Neoplasms/diagnostic imaging [MeSH], Surgery, Computer-Assisted/methods [MeSH], Prostate/diagnostic imaging [MeSH], PSMA-radioguided surgery, PSA recurrence, Gallium Radioisotopes [MeSH], Male [MeSH], Neoplasm Recurrence, Local/diagnostic imaging [MeSH], Prostate/surgery [MeSH], PSMA PET/CT, Prostate-Specific Antigen/metabolism [MeSH], Positron Emission Tomography Computed Tomography/methods [MeSH], Prostatic Neoplasms/surgery [MeSH], Prostatectomy/methods [MeSH], Prostate cancer, Neoplasm Recurrence, Local, Retrospective Studies
-
12
Authors: et al.
Source: Radiat Oncol
Radiation Oncology, Vol 19, Iss 1, Pp 1-11 (2024)Subject Terms: Antigens, Surface/analysis [MeSH], Positron emission tomography, Glutamate Carboxypeptidase II/metabolism [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Humans [MeSH], Prognostic value, Prostatic Neoplasms/metabolism [MeSH], Radiopharmaceuticals [MeSH], Prostate-specific membrane antigen, Prostatic Neoplasms/pathology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Antigens, Surface/metabolism [MeSH], Prostatic Neoplasms/diagnostic imaging [MeSH], PSMA, Prostatic Neoplasms/radiotherapy [MeSH], Positron-Emission Tomography/methods [MeSH], Male [MeSH], Research, Prognosis [MeSH], Quantitative PET parameters, Prostate cancer, Male, Glutamate Carboxypeptidase II, R895-920, Medical physics. Medical radiology. Nuclear medicine, 03 medical and health sciences, 0302 clinical medicine, Humans, RC254-282, Retrospective Studies, Aged, Aged, 80 and over, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prostatic Neoplasms, Middle Aged, Prognosis, 3. Good health, Positron-Emission Tomography, Antigens, Surface, Radiopharmaceuticals
-
13
Authors: et al.
Contributors: et al.
Source: J Exp Clin Cancer Res
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-14 (2024)
Journal of experimental & clinical cancer research, 43(1):194Subject Terms: AR, Androgen deprivation therapy, Meeting Report, NR3C4, Humans [MeSH], Prostatic Neoplasms/metabolism [MeSH], Receptors, Androgen/metabolism [MeSH], PSMA, Receptors, Androgen/genetics [MeSH], PCa, Prostatic Neoplasms/genetics [MeSH], Male [MeSH], Prostatic Neoplasms/therapy [MeSH], 0301 basic medicine, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Cancers, RC254-282
File Description: application/pdf
-
14
Authors: et al.
Contributors: et al.
Source: Radiat Oncol
Radiation Oncology, Vol 19, Iss 1, Pp 1-16 (2024)Subject Terms: Male, 0301 basic medicine, DNA Repair, Medizin, R895-920, Heavy Ion Radiotherapy, Photon irradiation, Androgen receptor, TP53, Prostate cancer, Carbon ion irradiation, Medical physics. Medical radiology. Nuclear medicine, 03 medical and health sciences, Cell Line, Tumor, Humans, ddc:610, Cell Line, Tumor [MeSH], DNA Repair [MeSH], Heavy Ion Radiotherapy [MeSH], Humans [MeSH], Prostatic Neoplasms/metabolism [MeSH], Receptors, Androgen/metabolism [MeSH], Transcriptome/radiation effects [MeSH], Signal Transduction/radiation effects [MeSH], Prostatic Neoplasms/pathology [MeSH], Tumor Suppressor Protein p53/metabolism [MeSH], Prostatic Neoplasms/radiotherapy [MeSH], Receptors, Androgen/genetics [MeSH], Gene Expression Regulation, Neoplastic/drug effects [MeSH], Photons [MeSH], Carbon [MeSH], DNA Damage/radiation effects [MeSH], Male [MeSH], Gene Expression Regulation, Neoplastic/radiation effects [MeSH], Research, RC254-282, Photons, 0303 health sciences, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prostatic Neoplasms, Medical sciences Medicine, Carbon, 3. Good health, Gene Expression Regulation, Neoplastic, Receptors, Androgen, Tumor Suppressor Protein p53, Transcriptome, DNA Damage, Signal Transduction
-
15
Authors:
Source: J Exp Clin Cancer Res
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-19 (2024)Subject Terms: Male, 0301 basic medicine, Mice, 03 medical and health sciences, Cell Line, Tumor, Basic Helix-Loop-Helix Transcription Factors, Clock gene, Humans, Animals, RC254-282, Cellular Senescence, Bipolar androgen therapy, Gene Expression Regulation, Neoplastic [MeSH], Cell Line, Tumor [MeSH], Prostatic Neoplasms/metabolism [MeSH], Receptors, Androgen/metabolism [MeSH], Prostatic Neoplasms/drug therapy [MeSH], Prostatic Neoplasms/pathology [MeSH], Androgens/metabolism [MeSH], Receptors, Androgen/genetics [MeSH], Male [MeSH], Xenograft Model Antitumor Assays [MeSH], Basic Helix-Loop-Helix Transcription Factors/metabolism [MeSH], Prostate cancer, Androgens/pharmacology [MeSH], Cellular Senescence [MeSH], Humans [MeSH], Homeodomain Proteins/genetics [MeSH], Androgen-induced cellular senescence, Animals [MeSH], Prostatic Neoplasms/genetics [MeSH], Mice [MeSH], Basic Helix-Loop-Helix Transcription Factors/genetics [MeSH], Homeodomain Proteins/metabolism [MeSH], Research, Androgen receptor, Homeodomain Proteins, 0303 health sciences, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prostatic Neoplasms, Xenograft Model Antitumor Assays, 3. Good health, Gene Expression Regulation, Neoplastic, Receptors, Androgen, Androgens
-
16
Authors: et al.
Source: Mol Cancer
Molecular Cancer, Vol 23, Iss 1, Pp 1-21 (2024)
Molecular CancerSubject Terms: Male, 0301 basic medicine, Cancer Research, Prostatic Neoplasmspathologygeneticsmetabolism, Animals, Mice, Humans, PTEN Phosphohydrolasegeneticsmetabolism, Disease Progression, Tumor Microenvironmentimmunology, Senescence-Associated Secretory Phenotype, Proto-Oncogene Proteins c-junmetabolism, Gene Expression Regulation, Neoplastic, Cell Line, Tumor, Gene Expression Profiling, Cellular Senescencegenetics, Disease Models, Animal, Proto-Oncogene Proteins c-jun, AP-1 transcription factors, Senescence, SASP, Gene Expression Regulation, Neoplastic [MeSH], Cell Line, Tumor [MeSH], Disease Progression [MeSH], Immune infiltration, Prostatic Neoplasms/metabolism [MeSH], Prostatic Neoplasms/pathology [MeSH], Tumor Microenvironment/immunology [MeSH], Male [MeSH], Cellular Senescence/genetics [MeSH], Disease Models, Animal [MeSH], Prostate cancer, Humans [MeSH], PTEN Phosphohydrolase/genetics [MeSH], Animals [MeSH], Prostatic Neoplasms/genetics [MeSH], PTEN Phosphohydrolase/metabolism [MeSH], Proto-Oncogene Proteins c-jun/metabolism [MeSH], Mice [MeSH], Research, JUN, Gene Expression Profiling [MeSH], Senescence-Associated Secretory Phenotype [MeSH], 03 medical and health sciences, 106023 Molekularbiologie, SDG 3 - Good Health and Well-being, Tumor Microenvironment, 302055 Oncology, RC254-282, Cellular Senescence, Cancer och onkologi, 0303 health sciences, 302055 Onkologie, PTEN Phosphohydrolase, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prostatic Neoplasms, 106023 Molecular biology, 3. Good health, Cancer and Oncology, SDG 3 – Gesundheit und Wohlergehen, Integrative Biomedicine [Topic 3]
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/38811984
https://doaj.org/article/adefb22c8cb94d6696ce31c1da5a32f5
https://edoc.mdc-berlin.de/id/eprint/24419/1/24419oa.pdf
https://repository.publisso.de/resource/frl:6497250
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-225946
http://urn.kb.se/resolve?urn=urn:nbn:se:mau:diva-70049 -
17
Authors: et al.
Contributors: et al.
Source: Oncogene
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Universidad de Zaragoza
Scott, E, Hodgson, K, Calle, B, Turner, H, Cheung, K, Bermudez, A, Marques, F J G, Pye, H, Yo, E C, Islam, K, Oo, H Z, McClurg, U L, Wilson, L, Thomas, H, Frame, F M, Orozco-Moreno, M, Bastian, K, Arredondo, H M, Roustan, C, Gray, M A, Kelly, L, Tolson, A, Mellor, E, Hysenaj, G, Goode, E A, Garnham, R, Duxfield, A, Heavey, S, Stopka-Farooqui, U, Haider, A, Freeman, A, Singh, S, Johnston, E W, Punwani, S, Knight, B, McCullagh, P, McGrath, J, Crundwell, M, Harries, L, Bogdan, D, Westaby, D, Fowler, G, Flohr, P, Yuan, W, Sharp, A, de Bono, J, Maitland, N J, Wisnovsky, S, Bertozzi, C R, Heer, R, Guerrero, R H, Daugaard, M, Leivo, J, Whitaker, H, Pitteri, S, Wang, N, Elliott, D J, Schumann, B & Munkley, J 2023, ' Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth ', Oncogene, vol. 42, pp. 926–937 . https://doi.org/10.1038/s41388-023-02604-xSubject Terms: Male, Transcriptional Activation, Chemical Biology & High Throughput, 0301 basic medicine, 0303 health sciences, Glycosylation, Prostatic Neoplasms/metabolism, Prostatic Neoplasms, Cell Biology, Tumour Biology, Biochemistry & Proteomics, Article, Up-Regulation, 3. Good health, 03 medical and health sciences, Metabolism, Humans, Synthetic Biology, Signal Transduction, Structural Biology & Biophysics
File Description: application/pdf; Print-Electronic
-
18
Authors: et al.
Source: Medical Physics. 49:6547-6559
Subject Terms: Male, Tumor, Microbubbles, Contrast Media/chemistry, pharmacokinetic modeling, Contrast Media, Prostatic Neoplasms, Ultrasonography/methods, Prostatic Neoplasms/metabolism, molecular imaging, prostate cancer, SDG 3 – Goede gezondheid en welzijn, Cell Line, 3. Good health, Mice, 03 medical and health sciences, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Cell Line, Tumor, Animals, Humans, contrast-enhanced ultrasound, nanobubbles, Ultrasonography
-
19
Authors: et al.
Source: J Transl Med
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-8 (2024)Subject Terms: EXPRESSION, Male, PCa, CASTRATION, Immunology, NR3C4, Research & Experimental Medicine, Androgen deprivation therapy, Meeting Report, DIAGNOSIS, MECHANISMS, SDG 3 - Good Health and Well-being, Humans, CLINICAL-SIGNIFICANCE, 11 Medical and Health Sciences, Science & Technology, 42 Health sciences, Humans [MeSH], Prostatic Neoplasms/metabolism [MeSH], Prostatic Neoplasms, Castration-Resistant/drug therapy [MeSH], Receptors, Androgen/metabolism [MeSH], Prostatic Neoplasms, Castration-Resistant/metabolism [MeSH], Androgen Antagonists/therapeutic use [MeSH], Male [MeSH], Signal Transduction [MeSH], Combination strategies, Androgen receptor, Biomarkers [MeSH], Prostatic Neoplasms, Androgen Antagonists, SUPERFAMILY, 32 Biomedical and clinical sciences, GENE, CIRCULATING TUMOR-CELLS, GLUCOCORTICOID-RECEPTOR, 3. Good health, Prostatic Neoplasms, Castration-Resistant, Medicine, Research & Experimental, Receptors, Androgen, Medicine, Life Sciences & Biomedicine, RESISTANCE, Biomarkers, Signal Transduction
-
20
Authors: et al.
Source: Cancer Epidemiology, Biomarkers and Prevention. 17(7):1682-1688
Subject Terms: Aged, DNA, Neoplasm/*genetics, Follow-Up Studies, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Humans, In Situ Hybridization, Fluorescence, Male, Phenotype, Prognosis, Prostatic Neoplasms/metabolism/*mortality/pathology, Retrospective Studies, Serine Endopeptidases/biosynthesis/*genetics, Severity of Illness Index, Survival Rate/trends, Sweden/epidemiology, Time Factors, MEDICINE, MEDICIN, Surgery, Kirurgi, Oncology, Onkologi
File Description: print
Full Text 
Full Text Finder 
Nájsť tento článok vo Web of Science